PKC theta, a novel immunohistochemical marker for gastrointestinal stromal tumors (GIST), especially useful for identifying KIT-negative tumors.
Gastrointestinal stromal tumor (GIST) is the most common mesenchymal tumor in the digestive tract and the majority of GIST has characteristic gain-of-function mutations of the c-kit gene, which encodes the KIT receptor for stem cell factor. The present study aimed to establish the usefulness of protein kinase C theta (PKC theta) as an immunohistochemical marker for GIST in comparison with KIT immunohistochemistry. PKC theta immunohistochemistry was carried out not only on 48 cases of GIST and another 40 cases of gastrointestinal mesenchymal tumors, but also on 24 cases of various tumors known to be immunohistochemically positive for KIT. Immunohistochemically, 41 out of 48 cases (85%) of GIST were positive for PKC theta, and its expression was confirmed by Western blot analysis using six cases of surgically resected GIST. In the present study there were six GIST immunohistochemically negative for KIT, which histologically revealed a myxoid epithelioid appearance characteristic to that of GIST with platelet-derived growth factor receptor alpha mutation. All six GIST were immunohistochemically positive for PKC theta. No PKC theta immunoreactivity was observed in other gastrointestinal mesenchymal tumors and various KIT-positive tumors except for three cases (14%) of gastrointestinal schwannomas. The present study revealed that PKC theta is an immunohistochemically novel and useful marker for GIST, especially for GIST negative for KIT.
Motegi
Atsushi
A
Department of Tumor Pathology, Graduate School of Medicine, Gunma University, Maebashi-shi, Gunma, Japan. amotegi@med.gunma-u.ac.jp
Sakurai
Shinji
S
Nakayama
Hiroko
H
Sano
Takaaki
T
Oyama
Tetsunari
T
Nakajima
Takashi
T
D014408:Biomarkers, Tumor / Q000378:metabolism; D015153:Blotting, Western; D005770:Gastrointestinal Neoplasms / Q000378:metabolism* / Q000473:pathology / Q000601:surgery; D006801:Humans; D007124:Immunoenzyme Techniques / Q000379:methods*; D007527:Isoenzymes / Q000378:metabolism*; D008637:Mesenchymoma / Q000378:metabolism* / Q000556:secondary / Q000601:surgery; D011493:Protein Kinase C / Q000378:metabolism*; D000074121:Protein Kinase C-theta; D019009:Proto-Oncogene Proteins c-kit / Q000378:metabolism*; D017154:Stromal Cells / Q000378:metabolism* / Q000473:pathology
D014408:Biomarkers, Tumor; D007527:Isoenzymes; D019009:Proto-Oncogene Proteins c-kit; C076233:PRKCQ protein, human; D011493:Protein Kinase C; D000074121:Protein Kinase C-theta